More than 4,000 children are diagnosed with a brain tumor each year and today it’s the leading cause of cancer-related deaths in children under the age of 10. To drive progress in pediatrics, National Brain Tumor Society has committed to direct one-third of its research budget toward this area, including Project Impact.
Glioblastoma multiforme (GBM) is a highly aggressive and the deadliest form of brain cancer, effecting hundreds of people each day. Today, only 5%-10% of all diagnosed with a GBM will live beyond 5 years. National Brain Tumor Society created the Defeat GBM Research Collaborative to accelerate progress and dramatically improve patient survival rates. Our aim is to double the amount of patients who live beyond 5 years.
Oligodendroglioma is a rare brain tumor, representing only 6% of all gliomas. Given its rarity, not much is known about this tumor type, and treatment options are limited. To support those affected, the National Brain Tumor Society created the Oligodendroglioma Research Fund to uncover new and better treatments for these patients.
Each year thousands of men, women, and children will be diagnosed with a brain tumor. Brain tumors cannot be prevented and treatment options are severely limited. And, brain tumors can strike anyone and anytime. We need your help to drive discovery and find a cure.